Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation

Author:

Alsina Katherina M.12,Hulsurkar Mohit23,Brandenburg Sören4,Kownatzki-Danger Daniel24,Lenz Christof5,Urlaub Henning5,Abu-Taha Issam6,Kamler Markus7,Chiang David Y.8,Lahiri Satadru K.23,Reynolds Julia O.23,Quick Ann P.23,Scott Larry23,Word Tarah A.23,Gelves Maria D.2,Heck Albert J.R.910,Li Na12311,Dobrev Dobromir612,Lehnart Stephan E.4,Wehrens Xander H.T.1231113

Affiliation:

1. Integrative Molecular and Biomedical Sciences (K.M.A., N.L., X.H.T.W.), Baylor College of Medicine, Houston, TX.

2. Cardiovascular Research Institute (K.MA., M.H., D.Y.C., S.K.L., J.O.R., A.P.Q., L.S., T.A.W., M.D.G., N.L., X.H.T.W.), Baylor College of Medicine, Houston, TX.

3. Department of Molecular Physiology & Biophysics (M.H., S.K.L., J.O.R., A.P.Q., L.S., T.A.W., N.L., X.H.T.W.), Baylor College of Medicine, Houston, TX.

4. Cellular Biophysics and Translational Cardiology Research Section, Heart Research Center Göttingen, and Department of Cardiology & Pneumology, University Medical Center of Göttingen, Germany (S.B., D.K.-D., S.E.L.).

5. Institute of Clinical Chemistry, University Medical Center Göttingen, and Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Germany (C.L., H.U.).

6. Institute of Pharmacology, West Germany Heart and Vascular Center (I.A.-T., D.D.), University Duisburg-Essen, Germany.

7. Department of Thoracic and Cardiovascular Surgery Huttrop (M.K.), University Duisburg-Essen, Germany.

8. Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (D.Y.C.).

9. Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands (A.J.R.H.).

10. Netherlands Proteomics Centre, Utrecht (A.J.R.H.).

11. Department of Medicine (Cardiology), Baylor College of Medicine (N.L., X.H.T.W.), Baylor College of Medicine, Houston, TX.

12. DZHK (German Centre for Cardiovascular Research) site Goettingen (S.E.L.).

13. Department of Pediatrics (Cardiology) (X.H.T.W.), Baylor College of Medicine, Houston, TX.

Abstract

Background: Abnormal calcium (Ca 2+ ) release from the sarcoplasmic reticulum (SR) contributes to the pathogenesis of atrial fibrillation (AF). Increased phosphorylation of 2 proteins essential for normal SR-Ca 2+ cycling, the type-2 ryanodine receptor (RyR2) and phospholamban (PLN), enhances the susceptibility to AF, but the underlying mechanisms remain unclear. Protein phosphatase 1 (PP1) limits steady-state phosphorylation of both RyR2 and PLN. Proteomic analysis uncovered a novel PP1-regulatory subunit (PPP1R3A [PP1 regulatory subunit type 3A]) in the RyR2 macromolecular channel complex that has been previously shown to mediate PP1 targeting to PLN. We tested the hypothesis that reduced PPP1R3A levels contribute to AF pathogenesis by reducing PP1 binding to both RyR2 and PLN. Methods: Immunoprecipitation, mass spectrometry, and complexome profiling were performed from the atrial tissue of patients with AF and from cardiac lysates of wild-type and Pln -knockout mice. Ppp1r3a -knockout mice were generated by CRISPR-mediated deletion of exons 2 to 3. Ppp1r3a -knockout mice and wild-type littermates were subjected to in vivo programmed electrical stimulation to determine AF susceptibility. Isolated atrial cardiomyocytes were used for Stimulated Emission Depletion superresolution microscopy and confocal Ca 2+ imaging. Results: Proteomics identified the PP1-regulatory subunit PPP1R3A as a novel RyR2-binding partner, and coimmunoprecipitation confirmed PPP1R3A binding to RyR2 and PLN. Complexome profiling and Stimulated Emission Depletion imaging revealed that PLN is present in the PPP1R3A-RyR2 interaction, suggesting the existence of a previously unknown SR nanodomain composed of both RyR2 and PLN/sarco/endoplasmic reticulum calcium ATPase-2a macromolecular complexes. This novel RyR2/PLN/sarco/endoplasmic reticulum calcium ATPase-2a complex was also identified in human atria. Genetic ablation of Ppp1r3a in mice impaired binding of PP1 to both RyR2 and PLN. Reduced PP1 targeting was associated with increased phosphorylation of RyR2 and PLN, aberrant SR-Ca 2+ release in atrial cardiomyocytes, and enhanced susceptibility to pacing-induced AF. Finally, PPP1R3A was progressively downregulated in the atria of patients with paroxysmal and persistent (chronic) AF. Conclusions: PPP1R3A is a novel PP1-regulatory subunit within the RyR2 channel complex. Reduced PPP1R3A levels impair PP1 targeting and increase phosphorylation of both RyR2 and PLN. PPP1R3A deficiency promotes abnormal SR-Ca 2+ release and increases AF susceptibility in mice. Given that PPP1R3A is downregulated in patients with AF, this regulatory subunit may represent a new target for AF therapeutic strategies.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference49 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3